Neuchâtel, 18 October 2010. How can biomedical and pharmaceutical research and development be stimulated in Switzerland in order to fight neglected diseases (Chagas, Dengue fever or river blindness)? A researcher of the Institute of Health Law at the University of Neuchâtel sheds light on this question in a book that has just been released. Read more on the UNINE page…
Recent Posts
- New publication from the ATP consortium
- New Publication on Socially Responsible Licensing Initiatives in South Africa
- New publication on R&D for Neglected Diseases from the University of Neuchâtel
- Compulsory licensing of an antiretroviral in Brazil
- St. George’s Global Health Forum, and local UAEM Chapter
Recent Comments
- roberto glasser on Compulsory licensing of an antiretroviral in Brazil
0 Response to “New publication on R&D for Neglected Diseases from the University of Neuchâtel”